Review of the Evidence on Preventing and Managing Acute Kidney Injury after Cardiac Surgery with Amino Acids
,
Abstract
Background: Acute kidney injury (AKI) after cardiac surgery leads to serious outcomes, including higher mortality and increased risk of chronic kidney disease. The pathophysiology includes hemodynamic changes, inflammation, and direct renal damage. Key risk factors are chronic kidney disease, older age, diabetes, hypertension, and surgical issues like cardiopulmonary bypass (CPB) and nephrotoxic agents. CPB can cause inflammation, worsening renal blood flow and glomerular filtration rate (GFR). Preventing AKI requires a comprehensive approach that encompasses preoperative optimization, intraoperative management, and postoperative care. Important strategies include optimizing the CPB circuit, using blood cardioplegia for better myocardial and renal protection, and managing fluid balance. This study aimed to examine the factors leading to acute kidney injury during heart surgery and to identify strategies for addressing it.
Methods: Research articles from information sources and databases over the past five years were analyzed using keywords. The studies were classified and summarized according to the disease's pathophysiology and management strategies, and clinically evaluated. The findings were assessed based on clinical evidence and compiled into a review article.
Results: Amino acids are essential for renal protection, as they enhance blood flow, improve GFR, scavenge reactive oxygen species (ROS), modulate inflammation, support cellular energy, inhibit apoptosis, aid in protein synthesis, and maintain renal autoregulation. Specific amino acids, including L-Arginine, L-Citrulline, L-Carnitine, Taurine, L-Glutamine, L-Cysteine, L-Methionine, L-Ornithine, L-Tyrosine, and Branched-Chain Amino Acids (BCAAs), have demonstrated protective effects. These amino acids can enhance postoperative GFR and potentially lower the risk of AKI by bolstering renal functional reserve and stimulating local renal growth factors.
Conclusion: A comprehensive strategy incorporating preoperative, intraoperative, and postoperative measures, along with the judicious use of amino acids, is essential for preventing AKI and improving outcomes in patients undergoing cardiac surgery.
[2] Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009; 119:2444–2453
[3] Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care. 2012; 16:1-4
[4] Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017; 43:1551-61.
[5] Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013; 17:204-204.
[6] Boyer N, Eldridge J, Prowle JR, Forni LG. Postoperative acute kidney injury. Clin J Am Soc Nephrol. 2022; 17: 1535-45.
[7] Ronco C. Acute kidney injury: from clinical to molecular diagnosis. Crit Care. 2016; 20:201
[8] McIlroy DR, Argenziano M, Farkas D, Umann T, Sladen RN. Incorporating oliguria into the diagnostic criteria for acute kidney injury after on-pump cardiac surgery: impact on incidence and outcomes. J Cardiothorac Vasc Anesth. 2013; 27:1145–1152
[9] Bastin AJ, Ostermann M, Slack AJ, Diller GP, Finney SJ, Evans TW. Acute kidney injury after cardiac surgery according to Risk/Injury/Failure/Loss/Endstage, Acute Kidney Injury Network, and Kidney Disease: Improving Global Outcomes classifications. J Crit Care. 2013; 28: 389-96.
[10] Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016; 315:877–888
[11] Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015; 313:2133–2141
[12] Kazawa M, Kabata D, Yoshida H, Minami K, Maeda T, Yoshitani K, et al. Amino acids to prevent cardiac surgery-associated acute kidney injury: a randomized controlled trial. JA Clin Rep. 2024; 10:19-19.
[13] Doig GS, Simpson F, Bellomo R, Heighes PT, Sweetman EA, Chesher D, et al. Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med. 2015; 41: 1197-208.
[14] Jeppsson A, Ekroth R, Friberg P, Kirnö K, Milocco I, Nilsson F, et al. Renal effects of amino acid infusion in cardiac surgery. J Cardiothorac Vasc Anesth. 2000; 14: 51-5.
[15] Jabbari A, Nooralishahi B, Amirkhanlou S, Khori V. Prime Solution and Administration of Albumin in Pediatric Heart Surgery. Arch Anesthesiol Crit Care. 2023; 9(1): 80-83.
[16] Landoni G, Monaco F, Ti LK, Baiardo Redaelli M, Bradic N, Comis M, et al. A randomized trial of intravenous amino acids for kidney protection. N Engl J Med. 2024; 391:687-698.
[17] Husain-Syed F, Emlet DR, Wilhelm J, Danesi TH, Ferrari F, Bezerra P, et al. Effects of preoperative high-oral protein loading on short- and long-term renal outcomes following cardiac surgery: a cohort study. J Transl Med. 2022; 20:204-204.
[18] Husain-Syed F, Ferrari F, Sharma A, Hinna Danesi T, Bezerra P, Lopez-Giacoman S, et al. Persistent decrease of renal functional reserve in patients after cardiac surgery associated acute kidney injury despite clinical recovery. Nephrol Dial Transplant. 2019; 34: 308-17.
| Files | ||
| Issue | Article in Press |
|
| Section | Review Article(s) | |
| Keywords | ||
| Acute kidney injury cardiac surgery amino acids prevention management | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
